About the Authors
- Tzu-Yuan Chao
-
Roles Writing – original draft
* E-mail: cchao@synermore.com
Affiliation Synermore Biologics Co., Ltd., Taipei, Taiwan
- Shiqi Ren
-
Roles Data curation, Investigation
Affiliation Synermore Biologics Co., Ltd., Taipei, Taiwan
- Enyun Shen
-
Roles Methodology, Project administration
Affiliation Beijing Cotimes Biotech Co., Ltd., Beijing, China
- Susan Moore
-
Roles Investigation, Methodology
Affiliation Kansas State University Rabies Laboratory, Manhattan, Kansas State, United States of America
- Shou-feng Zhang
-
Roles Investigation, Methodology, Resources
Affiliation Laboratory of Epidemiology and Key Laboratory of Jilin Provincial Zoonosis Control and Prevention, Military Veterinary Research Institute, Academy of Military Medical Sciences, Changchun, China
- Li Chen
-
Roles Writing – review & editing
Affiliation Synermore Biologics Co., Ltd., Taipei, Taiwan
- Charles E. Rupprecht
-
Roles Methodology, Writing – review & editing
Affiliation LYSSA LLC, Atlanta, Georgia, United States of America
- Eric Tsao
-
Roles Funding acquisition, Supervision
Affiliation Synermore Biologics Co., Ltd., Taipei, Taiwan
Competing Interests
The authors SR and ES are listed as inventors on a patent application (WO2013174003 A1 "Compositions and methods related to prevention and treatment of rabies infection") covering the subject matter of the study. Specifically, the compositions of the antibodies discussed in the manuscript, CTB011 and CTB012, constitute major claims of the patent. Data for Figs 1, S2 and S3 of this manuscript was also described in the patent. This does not alter the authors' adherence to PLOS NTD policies on sharing data and materials. Authors TYC, SR, LC, and ET are funded and employed by Synermore Biologics Co., Ltd. The authors ES and CER are employees at Beijing Cotimes Biotech Co., Ltd. and Lyssa LLC respectively. The authors ES and CER are employees at Beijing Cotimes Biotech Co., Ltd. and Lyssa LLC, respectively.